ono 1078 has been researched along with Carcinoma, Lewis Lung in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In addition, a Lewis lung carcinoma metastasis model in mice was used to study the inhibitory effect of pranlu kast and montelukast against cancer cell extravasation through general capillaries." | 1.36 | Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability. ( Houkin, K; Imai, K; Ishitani, K; Ito, Y; Kobayashi, H; Muraki, T; Nozaki, M; Yoshikawa, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozaki, M | 1 |
| Yoshikawa, M | 1 |
| Ishitani, K | 1 |
| Kobayashi, H | 1 |
| Houkin, K | 1 |
| Imai, K | 1 |
| Ito, Y | 1 |
| Muraki, T | 1 |
1 other study available for ono 1078 and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability.
Topics: Acetates; Animals; Capillary Permeability; Carcinoma, Lewis Lung; Cell Line, Tumor; Chromones; Colon | 2010 |